250 related articles for article (PubMed ID: 18479257)
1. The Interleukin-23 / Interleukin-17 axis in intestinal inflammation.
Maloy KJ
J Intern Med; 2008 Jun; 263(6):584-90. PubMed ID: 18479257
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-23 axis in intestinal inflammation.
Ahern PP; Izcue A; Maloy KJ; Powrie F
Immunol Rev; 2008 Dec; 226():147-59. PubMed ID: 19161422
[TBL] [Abstract][Full Text] [Related]
3. IL-23 and Th17 cytokines in intestinal homeostasis.
Maloy KJ; Kullberg MC
Mucosal Immunol; 2008 Sep; 1(5):339-49. PubMed ID: 19079198
[TBL] [Abstract][Full Text] [Related]
4. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease.
Liu ZJ; Yadav PK; Su JL; Wang JS; Fei K
World J Gastroenterol; 2009 Dec; 15(46):5784-8. PubMed ID: 19998498
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
[TBL] [Abstract][Full Text] [Related]
6. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
Shen W; Durum SK
Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
[TBL] [Abstract][Full Text] [Related]
7. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
8. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
9. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
[TBL] [Abstract][Full Text] [Related]
10. Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance.
Li Q; Shan Q; Sang X; Zhu R; Chen X; Cao G
Am J Chin Med; 2019; 47(1):177-201. PubMed ID: 30612460
[TBL] [Abstract][Full Text] [Related]
11. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-23/Th17 pathways and inflammatory bowel disease.
Abraham C; Cho J
Inflamm Bowel Dis; 2009 Jul; 15(7):1090-100. PubMed ID: 19253307
[TBL] [Abstract][Full Text] [Related]
14. Innate and adaptive immunity in inflammatory bowel disease.
Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
[TBL] [Abstract][Full Text] [Related]
15. New pathogenic paradigms in inflammatory bowel disease.
Di Sabatino A; Biancheri P; Rovedatti L; MacDonald TT; Corazza GR
Inflamm Bowel Dis; 2012 Feb; 18(2):368-71. PubMed ID: 21538717
[TBL] [Abstract][Full Text] [Related]
16. A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.
Vyas SP; Goswami R
Front Immunol; 2018; 9():1139. PubMed ID: 29881387
[TBL] [Abstract][Full Text] [Related]
17. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited.
Boniface K; Blom B; Liu YJ; de Waal Malefyt R
Immunol Rev; 2008 Dec; 226():132-46. PubMed ID: 19161421
[TBL] [Abstract][Full Text] [Related]
18. IL-23 in inflammatory bowel diseases and colon cancer.
Neurath MF
Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
[TBL] [Abstract][Full Text] [Related]
19. IL-23/IL-17 axis in IBD.
Sarra M; Pallone F; Macdonald TT; Monteleone G
Inflamm Bowel Dis; 2010 Oct; 16(10):1808-13. PubMed ID: 20222127
[TBL] [Abstract][Full Text] [Related]
20. Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis.
Ray S; De Salvo C; Pizarro TT
Curr Opin Gastroenterol; 2014 Nov; 30(6):531-8. PubMed ID: 25255234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
